MethodsJournal of Pharmacology and PharmacotherapeuticsVol. 2 | Issue 4 | 2011 | pp. 295–299Open access
Starting a pharmacovigilance center: Actions for implementation
- 1*,
- 1
- 1 Department of Pharmacology, Veer Chandra Singh Garhwali Govt. Medical Science and Research Institute, Srinagar - 246 174, Garhwal, Uttarakhand, India Methods.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Mrinmoy Chakrabarty
Department of Pharmacology, Veer Chandra Singh Garhwali Govt. Medical Science and Research Institute, Srinagar - 246 174, Garhwal, Uttarakhand, India Methods.
Copyright: © 2011 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2011
How to cite
Chakrabarty, M., & Thawani, V. (2011). Starting a pharmacovigilance center: Actions for implementation. Journal of Pharmacology and Pharmacotherapeutics, 2(4), 295–299. https://doi.org/10.4103/0976-500X.85945
Abstract
With burgeoning reports of adverse drug reactions due to pharmacotherapy, pharmacovigilance (PV) is the buzz word in health care circles. While there are experts in this rapidly expanding fi eld, there are many health care professionals who do not fully appreciate the import of PV in the context of modern therapeutics. In view of the national directive to institutionalize a PV center in every medical college of India, there is an urgent need to inform, educate, and enlighten the readers about the constitution and dynamics of a PV center, which this article attempts to fulfi ll.
Keywords
Subject
Article metadata
| Title | Starting a pharmacovigilance center: Actions for implementation |
|---|---|
| Authors | Mrinmoy Chakrabarty; Vijay Thawani |
| Affiliations | Department of Pharmacology, Veer Chandra Singh Garhwali Govt. Medical Science and Research Institute, Srinagar - 246 174, Garhwal, Uttarakhand, India Methods. |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 2, Issue 4 (2011) |
Also in this issue
- ACE inhibitor and angiotensin-receptor blocker – A deadly combinationpp. 311–312
- The National Formulary of India 2010: Thorough and extensive revision of the preprint version neededpp. 219–20
- Research publications: Should they be mandatory for promotions of medical teachers?pp. 221–222
- The curious case of zinc for diarrhea: Unavailable, unprescribed, and unusedpp. 225–226
- Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellituspp. 230–235
Readers Also Viewed
Effect of the Fractions of Coccinia grandis on Ethanol- Induced Cerebral Oxidative Stress in Rats
M. Umamaheswari, T. K. Chatterjee
Jan 1, 2009
Phytochemical Screening and Antioxidant Activity Evaluation of Selected Philippine Fruit Peels and Pulps
Mildred Dagcuta Pates, Angelo Mark Po Walag, Romeo M. Del Rosario
Aug 17, 2026
Impact of Artificial Intelligence Assisted Drug Therapy Optimization on Drug Related Problems Amongst Older Adult Patients: A Systematic Review
Jehath Syed, Christy Thomas, Bavneet Kaur
Oct 23, 2026